| [1] |
Moch H, Cubilla AL, Humphrey PA, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours[J]. Eur Urol, 2016, 70(1): 93-105. DOI: 10.1016/j.eururo.2016.02.029.
|
| [2] |
|
| [3] |
Brouwer OR, Tagawa ST, Albersen M, et al. EAU-ASCO Penile Cancer Guidelines[J]. 2025.
URL
|
| [4] |
Yao K, Zou ZJ, Li ZS, et al. Fascia Lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome[J]. Urology, 2013, 82(3): 642-647. DOI: 10.1016/j.urology.2013.05.021.
|
| [5] |
Lont AP, Besnard APE, Gallee MPW, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma[J]. BJU Int, 2003, 91(6): 493-495. DOI: 10.1046/j.1464-410x.2003.04119.x.
|
| [6] |
Kayes O, Minhas S, Allen C, et al. The role of magnetic resonance imaging in the local staging of penile cancer[J]. Eur Urol, 2007, 51(5): 1313-1318;discussion1318-9. DOI: 10.1016/j.eururo.2006.11.014.
|
| [7] |
Hanchanale V, Yeo L, Subedi N, et al. The accuracy of magnetic resonance imaging (MRI) in predicting the invasion of the Tunica albuginea and the urethra during the primary staging of penile cancer[J]. BJU Int, 2016, 117(3): 439-443. DOI: 10.1111/bju.13041.
|
| [8] |
Wood HM, Angermeier KW. Anatomic considerations of the penis, lymphatic drainage, and biopsy of the sentinel node[J]. Urol Clin North Am, 2010, 37(3): 327-334. DOI: 10.1016/j.ucl.2010.04.013.
|
| [9] |
黄健.中国泌尿外科和男科疾病诊断治疗指南[M]. 北京: 科学出版社, 2022.
|
| [10] |
Agrawal A, Pai D, Ananthakrishnan N, et al. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications[J]. BJU Int, 2000, 85(3): 299-301. DOI: 10.1046/j.1464-410x.2000.00413.x.
|
| [11] |
Minhas S, Kayes O, Hegarty P, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer?[J]. BJU Int, 2005, 96(7): 1040-1043. DOI: 10.1111/j.1464-410X.2005.05769.x.
|
| [12] |
Philippou P, Shabbir M, Malone P, et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control[J]. J Urol, 2012, 188(3): 803-808. DOI: 10.1016/j.juro.2012.05.012.
|
| [13] |
Djajadiningrat RS, van Werkhoven E, Meinhardt W, et al. Penile sparing surgery for penile cancer-does it affect survival?[J]. J Urol, 2014, 192(1): 120-125. DOI: 10.1016/j.juro.2013.12.038.
|
| [14] |
Crook J, Jezioranski J, Cygler JE. Penile brachytherapy: technical aspects and postimplant issues[J]. Brachytherapy, 2010, 9(2): 151-158. DOI: 10.1016/j.brachy.2009.05.005.
|
| [15] |
de Crevoisier R, Slimane K, Sanfilippo N, et al. Long-term results of brachytherapy for carcinoma of the penis confined to the Glans (N- or NX)[J]. Int J Radiat Oncol Biol Phys, 2009, 74(4): 1150-1156. DOI: 10.1016/j.ijrobp.2008.09.054.
|
| [16] |
Dickstein RJ, Munsell MF, Pagliaro LC, et al. Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy[J]. BJU Int, 2016, 117(1): 118-125. DOI: 10.1111/bju.12946.
|
| [17] |
Yan R, Ma H, Jiang L, et al. First-line programmed death receptor-1 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage IV penile cancer[J]. BJU Int, 2023, 131(2): 198-207. DOI: 10.1111/bju.15828.
|
| [18] |
An X, Guo SJ, Yan R, et al. Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma[J]. Cancer Cell, 2025, 43(5): 970-980.e3. DOI: 10.1016/j.ccell.2025.03.023.
|
| [19] |
Xiong L, Shan X, Ma H, et al. First-line PD-1 blockade combined with chemotherapy for stage IV penile squamous cell carcinoma: a multicenter retrospective study[J]. J Natl Compr Cancer Netw, 2024, 23(1):e247074. DOI: 10.6004/jnccn.2024.7074.
|
| [20] |
Marchioni M, Berardinelli F, De Nunzio C, et al. New insight in penile cancer[J]. Minerva Urol Nefrol, 2018, 70(6): :559-569. DOI: 10.23736/s0393-2249.18.03215-0.
|